3-D Matrix Ltd (7777) - Product Pipeline Analysis, 2018 Update

Date: November 29, 2018
Pages: 32
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
ID: 3B37E0DE825EN
Leaflet:

Download PDF Leaflet

3-D Matrix Ltd (7777) - Product Pipeline Analysis, 2018 Update
SUMMARY

3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applications in the field of surgical and medical regenerative medicine, cell therapy and drug discovery. 3-D Matrix's lead product, PuraMatrix caters to periodontal bone regeneration. The company has several collaborative agreements with academic research institutions, enterprises and medical institutions. The company operates across the US, France, the Netherlands, China and Singapore. 3-D Matrix is headquartered in Chiyoda-ku, Tokyo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company 3-D Matrix Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

NOTE: Out of security concerns GlobalData requires using corporate email address.
3-D Matrix Ltd Company Overview
3-D Matrix Ltd Company Snapshot
3-D Matrix Ltd Pipeline Products and Ongoing Clinical Trials Overview
3-D Matrix Ltd – Pipeline Analysis Overview
Business Description
3-D Matrix Ltd - Key Facts
3-D Matrix Ltd - Major Products and Services
3-D Matrix Ltd Pipeline Products by Development Stage
3-D Matrix Ltd Ongoing Clinical Trials by Trial Status
3-D Matrix Ltd Pipeline Products Overview
PuraMatrix Bone Void Filler
PuraMatrix Bone Void Filler Product Overview
PuraSINUS Gel
PuraSINUS Gel Product Overview
PuraStat Hemostat
PuraStat Hemostat Product Overview
PuraStat Hemostat Clinical Trial
TDM-511
TDM-511 Product Overview
TDM-623
TDM-623 Product Overview
TDM-641
TDM-641 Product Overview
TDM-651
TDM-651 Product Overview
3-D Matrix Ltd - Key Competitors
3-D Matrix Ltd - Key Employees
3-D Matrix Ltd - Key Employee Biographies
3-D Matrix Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
3-D Matrix Ltd, Recent Developments
May 10, 2018: Partnership Agreement concluded with DEMEDIC regarding sales and marketing of absorbable local hemostat “PuraStat” in Argentina
Apr 28, 2016: Partnership Agreement concluded with Kaplan regarding sales and marketing of absorbable local hemostat “PuraStat” in Chile
Apr 05, 2016: Patent Granted for “Cardiac Tissue Regeneration” with Self-Assembling Peptide Technology in Japan
Feb 22, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Mexico
Feb 15, 2016: 3-D Matrix: Announcement of Change of Representative Directors
Jan 25, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Thailand
Jan 22, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Australia
Dec 28, 2015: Partnership Agreement concluded with Transmedic regarding sales and marketing of PuraStat in Singapore, Malaysia and Brunei
Nov 04, 2015: Absorbable Hemostat “TDM-621” Product Registration Obtained in Brazil
Oct 05, 2015: Partnership Agreement concluded with Maquet Australia regarding sales and marketing of absorbable local hemostat PuraStatin Australia
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

3-D Matrix Ltd Pipeline Products and Ongoing Clinical Trials Overview
3-D Matrix Ltd Pipeline Products by Equipment Type
3-D Matrix Ltd Pipeline Products by Indication
3-D Matrix Ltd Ongoing Clinical Trials by Trial Status
3-D Matrix Ltd, Key Facts
3-D Matrix Ltd, Major Products and Services
3-D Matrix Ltd Number of Pipeline Products by Development Stage
3-D Matrix Ltd Pipeline Products Summary by Development Stage
3-D Matrix Ltd Ongoing Clinical Trials by Trial Status
3-D Matrix Ltd Ongoing Clinical Trials Summary
PuraMatrix Bone Void Filler - Product Status
PuraMatrix Bone Void Filler - Product Description
PuraSINUS Gel - Product Status
PuraSINUS Gel - Product Description
PuraStat Hemostat - Product Status
PuraStat Hemostat - Product Description
PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery
TDM-511 - Product Status
TDM-511 - Product Description
TDM-623 - Product Status
TDM-623 - Product Description
TDM-641 - Product Status
TDM-641 - Product Description
TDM-651 - Product Status
TDM-651 - Product Description
3-D Matrix Ltd, Key Employees
3-D Matrix Ltd, Key Employee Biographies
3-D Matrix Ltd, Subsidiaries
Glossary

LIST OF FIGURES

3-D Matrix Ltd Pipeline Products by Equipment Type
3-D Matrix Ltd Pipeline Products by Development Stage
3-D Matrix Ltd Ongoing Clinical Trials by Trial Status

COMPANIES MENTIONED

PharmaDesign Inc
Kaketsuken
CellSeed Inc
Capital Genomix, Inc
Aushon BioSystems Inc
Skip to top


Ask Your Question

3-D Matrix Ltd (7777) - Product Pipeline Analysis, 2018 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: